Skip Ribbon Commands
Skip to main content

Clinical Trials (For Public)

At SERI, we strongly believe that research is critical to discover new and innovative ways to deliver the best and most cost‐effective clinical care. We believe that our research makes a positive difference to the vision and lives of our patients and the community at large.

Vision loss robs people of their independence, mobility and quality of life. We are seeking for healthy volunteers  who can help us in our research endeavours by participating in our clinical trials, so that we are able to make a positive difference to patients’ vision and to their lives. SERI conducts clinical studies in a safe and confidential environment, and volunteers may be compensated for their time. Your support will indirectly facilitate research that will lead to better ways to tackle vision impairment and eye diseases in Singapore and beyond.

Join as a Trial Volunteer

Studies With On-Going Recruitment

ATOM 3 Clinical Trial: Join Us In Developing Early Treatment For Myopia

If your family has a history of myopia, did you know that your child is twice or thrice more likely to have it too? If your child develops myopia early, it more likely evolve to high myopia. Persons with high myopia are at greater risk of developing myopia complications such as early cataract, retinal degeneration/detachment and glaucoma later on in life.  

We are looking for clinical trial volunteers to help us see if a particular type of eye drops can prevent the onset of myopia or control its progression, and thereby prevent high myopia.

A child who meets the following criteria is eligible for this clinical trial:

  • Your child is between 5 to 9 years old
  • Either not yet wearing glasses OR has low myopia (less than -1.5D)
  • Has family history of myopia (one parent with myopia more than -3.00D)
  • Not currently receiving or had previously treatment (e.g. eye drops) for the treatment of myopia

If you are interested for your child to take part and wish to find out more, please contact +65 6322 4500 / +65 6322 4501 (Mondays- Fridays, 9am to 5 pm).

You may also leave your name and contact details via our phone answering service; or through our email address at

I am interested in ATOM3 Clinical Trial